Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 29

Results For "PLI"

4291 News Found

Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market
News | June 20, 2026

Zydus’s acquisition of Assertio to bolster its specialty pharma presence in US market

Upon completion of the merger, Assertio will become a wholly owned subsidiary of Zydus Lifesciences and will be delisted from the Nasdaq


Manipal Hospitals Mukundapur launches advanced Neuro Biplane Cathlab
Hospitals | June 20, 2026

Manipal Hospitals Mukundapur launches advanced Neuro Biplane Cathlab

State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India


AngioDynamics gets FDA nod for RELIEF trial to evaluate NanoKnife for enlarged prostate treatment
Medical Device | June 19, 2026

AngioDynamics gets FDA nod for RELIEF trial to evaluate NanoKnife for enlarged prostate treatment

Study will assess the safety and effectiveness of irreversible electroporation as a minimally invasive treatment option for benign prostatic hyperplasia (BPH)


Dr. Gullapalli N. Rao conferred SantokBaa Humanitarian Award 2026
Healthcare | June 19, 2026

Dr. Gullapalli N. Rao conferred SantokBaa Humanitarian Award 2026

LV Prasad Eye Institute founder recognized for his pioneering contribution to affordable and accessible eye care; award celebrates two decades of honoring transformative humanitarian leadership.


Moderna reshapes leadership and ops model as it pushes into oncology, rare disease
News | June 18, 2026

Moderna reshapes leadership and ops model as it pushes into oncology, rare disease

CEO Stéphane Bancel framed the changes as essential to scaling the business


Suven reports positive Phase 2b results for Ropanicant in major depressive disorder
Clinical Trials | June 18, 2026

Suven reports positive Phase 2b results for Ropanicant in major depressive disorder

Suven has already begun planning a global Phase 3 registrational program for MDD based on the results


Lupin secures 180-day exclusivity for generic Azilsartan Medoxomil tablets in U.S. market
Drug Approval | June 18, 2026

Lupin secures 180-day exclusivity for generic Azilsartan Medoxomil tablets in U.S. market

Company introduces bioequivalent version of Edarbi for hypertension treatment following U.S. FDA approval; product recorded annual U.S. sales of USD 53.5 million


proRITHM named among top 4 AI-based healthcare technologies
Digitisation | June 18, 2026

proRITHM named among top 4 AI-based healthcare technologies

AI-powered remote patient monitoring platform earns recognition at AI in Healthcare 2.0 for advancing continuous, preventive, and personalized healthcare delivery


Vygon secures Health Canada approval for next-generation Stiletto Extended-Dwell Catheter
Medical Device | June 17, 2026

Vygon secures Health Canada approval for next-generation Stiletto Extended-Dwell Catheter

Approval paves the way for expansion in North America’s growing vascular access market, with innovative SlipStream technology designed to simplify catheter insertion and enhance patient care


Can India become global clinical trials hub? Industry leaders to discuss road ahead on 19th June
News | June 17, 2026

Can India become global clinical trials hub? Industry leaders to discuss road ahead on 19th June

Leading experts from AIIMS Kalyani, Syngene, Veeda Lifesciences, Lambda Therapeutic, DNDi, JSS Medical, KIHT, InoRx, ISCR and SIRO Clintech to discuss India’s readiness as preferred clinical research destination